Regulation of adaptive immunity; the role of interleukin-10
- PMID: 23755052
- PMCID: PMC3668291
- DOI: 10.3389/fimmu.2013.00129
Regulation of adaptive immunity; the role of interleukin-10
Abstract
Since the discovery of interleukin-10 (IL-10) in the 1980s, a large body of work has led to its recognition as a pleiotropic immunomodulatory cytokine that affects both the innate and adaptive immune systems. IL-10 is produced by a wide range of cell types, but for the purposes of this review we shall focus on IL-10 secreted by CD4(+) T cells. Here we describe the importance of IL-10 as a mediator of suppression used by both FoxP3(+) and FoxP3(-) T regulatory cells. Moreover, we discuss the molecular events leading to the induction of IL-10 secretion in T helper cell subsets, where it acts as a pivotal negative feedback mechanism. Finally we discuss how a greater understanding of this principle has allowed for the design of more efficient, antigen-specific immunotherapy strategies to exploit this natural phenomenon clinically.
Keywords: T helper cells; allergy; autoimmunity; cytokines; immune regulation; immunotherapy; interleukin-10; regulatory T cells.
Figures



References
-
- Adris S., Klein S., Jasnis M., Chuluyan E., Ledda M., Bravo A., et al. (1999). IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response. Gene Ther. 6, 1705–171210.1038/sj.gt.3301012 - DOI - PubMed
-
- Akdis M., Verhagen J., Taylor A., Karamloo F., Karagiannidis C., Crameri R., et al. (2004). Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199, 1567–157510.1084/jem.20032058 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials